Rapilysin Европейски съюз - фински - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplaasia - sydäninfarkti - antitromboottiset aineet - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Ivomec vet 10 mg/ml injektioneste, liuos Финландия - фински - Fimea (Suomen lääkevirasto)

ivomec vet 10 mg/ml injektioneste, liuos

boehringer ingelheim animal health nordics a/s - ivermectin - injektioneste, liuos - 10 mg/ml - ivermektiini

Ivomec vet 18.7 mg/g oraalipasta Финландия - фински - Fimea (Suomen lääkevirasto)

ivomec vet 18.7 mg/g oraalipasta

boehringer ingelheim animal health nordics a/s - ivermectin - oraalipasta - 18.7 mg/g - ivermektiini

Noromectin Pour-on vet 5 mg/ml kertavaleluliuos Финландия - фински - Fimea (Suomen lääkevirasto)

noromectin pour-on vet 5 mg/ml kertavaleluliuos

norbrook laboratories (ireland) limited - ivermectin - kertavaleluliuos - 5 mg/ml - ivermektiini

Eraquell 18.7 mg/g oraalipasta Финландия - фински - Fimea (Suomen lääkevirasto)

eraquell 18.7 mg/g oraalipasta

virbac - ivermectin - oraalipasta - 18.7 mg/g - ivermektiini

Ivomec Comp oraalipasta Финландия - фински - Fimea (Suomen lääkevirasto)

ivomec comp oraalipasta

boehringer ingelheim animal health nordics a/s - praziquantel, ivermectin - oraalipasta - ivermektiini

Hippomectin 12 mg/g oraaligeeli Финландия - фински - Fimea (Suomen lääkevirasto)

hippomectin 12 mg/g oraaligeeli

le vet. b.v. - ivermectin - oraaligeeli - 12 mg/g - ivermektiini

ERAQUELL VET 20 mg purutabletti Финландия - фински - Fimea (Suomen lääkevirasto)

eraquell vet 20 mg purutabletti

virbac s.a. virbac s.a. - ivermectinum - purutabletti - 20 mg - ivermektiini

Imfinzi Европейски съюз - фински - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - karsinooma, ei-pienisoluinen keuhko - antineoplastiset aineet - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Ivermectin Medical Valley 3 mg tabletti Финландия - фински - Fimea (Suomen lääkevirasto)

ivermectin medical valley 3 mg tabletti

medical valley invest ab - ivermectin - tabletti - 3 mg - ivermektiini